| Dr Brentley Allen Buchele, MD | |
|
60 Four Mile Dr Ste 10, Kalispell, MT 59901-2663 | |
| (406) 756-2241 | |
| (406) 758-7062 |
| Full Name | Dr Brentley Allen Buchele |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 44 Years |
| Location | 60 Four Mile Dr Ste 10, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922052976 | NPI | - | NPPES |
| 000093226 | Other | MT | MT ID |
| 0152779 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 11056 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| North Valley Hospital | Whitefish, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
Women, and especially younger women, are much less likely than men to have good relief of chronic, non-cancer pain with long-term opioid use, with only one in five women reporting low levels of pain and high levels of function with chronic opioid therapy in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.
› Verified 6 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
Women, and especially younger women, are much less likely than men to have good relief of chronic, non-cancer pain with long-term opioid use, with only one in five women reporting low levels of pain and high levels of function with chronic opioid therapy in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.
› Verified 6 days ago
| Entity Name | Healthcenter Northwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982657466 PECOS PAC ID: 5799696423 Enrollment ID: O20050823001050 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
Women, and especially younger women, are much less likely than men to have good relief of chronic, non-cancer pain with long-term opioid use, with only one in five women reporting low levels of pain and high levels of function with chronic opioid therapy in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brentley Allen Buchele, MD 60 Four Mile Dr Ste 10, Kalispell, MT 59901-2663 Ph: (406) 756-2241 | Dr Brentley Allen Buchele, MD 60 Four Mile Dr Ste 10, Kalispell, MT 59901-2663 Ph: (406) 756-2241 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
Women, and especially younger women, are much less likely than men to have good relief of chronic, non-cancer pain with long-term opioid use, with only one in five women reporting low levels of pain and high levels of function with chronic opioid therapy in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.
› Verified 6 days ago
Dr. Bennett Jon Dykstra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1333 Surgical Services Way, Kalispell, MT 59901 Phone: 406-752-5000 Fax: 406-752-8220 | |
John R Craig, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1333 Surgical Services Way, Kalispell, MT 59901 Phone: 406-752-5000 | |
Neal W Wilkinson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1333 Surgical Services Way, Kalispell, MT 59901 Phone: 406-751-5392 Fax: 406-751-5406 | |
Michael Hromadka Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 60 Four Mile Dr, Suite 10, Kalispell, MT 59901 Phone: 406-756-2241 Fax: 406-758-7062 | |
Dr. Ida Mays Wilson, MD Surgery Medicare: Medicare Enrolled Practice Location: 1333 Surgical Services Way, Kalispell, MT 59901 Phone: 406-751-5392 Fax: 406-751-5406 | |
Randall S Zuckerman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1333 Surgical Services Way, Kalispell, MT 59901 Phone: 406-751-5392 | |
Mark V Mazziotti, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 202 Conway Dr Ste 200, Kalispell, MT 59901 Phone: 406-758-7490 Fax: 406-758-7080 |